The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Gonadotropin-releasing hormone agonist with add–back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis
Abstract
Purpose This study was performed to compare the efficacy and tolerability of GnRH agonist with add-back therapy versus dienogest treatment for preventing pelvic pain recurrence after laparoscopic surgery for endometriosis. Methods Sixty-four reproductive-aged women who underwent laparoscopic surgery for endometriosis received post-operative medical treatment with either GnRH agonist plus 17β-estradiol and norethisterone acetate (n = 28) or dienogest (n = 36) for 6 months. The pre- to post-treatment changes in pain were assessed using a visual analogue scale, and changes in quality-of-life and menopausal symptoms were measured by questionnaire. Results Visual analogue scale pain score decreased significantly for both treatments with no significant differences between groups. Neither physical, psychological, social, and environmental components of quality-of-life nor menopausal rating scale score were significantly different between the two groups. Bone mineral density at the lumbar spine declined significantly in both treatment groups (-2.5 % for GnRH agonist plus add-back and -2.3 % for dienogest), with no significant difference between the two groups. Conclusion GnRH agonist and add-back therapy using 17β-estradiol and norethisterone acetate are as effective and tolerable as dienogest for the prevention of pelvic pain recurrence after laparoscopic surgery for endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DNG is as effective and tolerable as GnRH agonist and add–back therapy using 17b-estradiol and NETA for 6 months for the prevention of pelvic pain recurrence after laparoscopic surgery for endometriosis [205].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [205]
In the citing paper
“DNG is an effective treatment also as postoperative treatment in order to reduce recurrences, to avoid re-interventions and to control pain symptoms.”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [205]
Citations
Cites
1 retracted
Laparoscopic surgery for pelvic pain associated with endometriosis
Jacobson, T. Z., Duffy, J. M., Barlow, D. H., Koninckx, P. R., & Garry, R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001300.pub2 · Cited by 219
RetractedESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
Recurrence of endometriosis and its control
Guo, S.-W. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp007 · Cited by 719
International versions of the Menopause Rating Scale (MRS).
Heinemann, L. A. J., Potthoff, P., & Schneider, H. P. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-28 · Cited by 520
Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., & Seitz, C. (2010) · Human Reproduction · doi:10.1093/humrep/dep469 · Cited by 381
The effect of surgery for symptomatic endometriosis: the other side of the story
Vercellini, P., Crosignani, P. G., Abbiati, A., Somigliana, E., Viganò, P., & Fedele, L. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmn062 · Cited by 339
Hormone treatment of endometriosis: The estrogenthreshold hypothesis
Barbieri, R. L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91706-g · Cited by 335
Harada, T., Momoeda, M., Taketani, Y., Aso, T., Fukunaga, M., Hagino, H., & Terakawa, N. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.080 · Cited by 279
Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study
Hornstein, M. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00620-0 · Cited by 243
Long‐term use of dienogest for the treatment of endometriosis
Momoeda, M., Harada, T., Terakawa, N., Aso, T., Fukunaga, M., Hagino, H., & Taketani, Y. (2009) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2009.01076.x · Cited by 192
Cited by
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Reevaluating response and failure of medical treatment of endometriosis: a systematic review
Becker, C. M., Gattrell, W. T., Gude, K., & Singh, S. S. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.05.004 · Cited by 302
“therapies include GnRH agonists, which induce a hypoestrogenic state resulting in menopausal symptoms, such as hot flushes, and are associated with reduced bone mineral density (4).”
BackgroundMedical treatment of endometriosis-related pain
Vercellini, P., Buggio, L., Frattaruolo, M. P., Borghi, A., Dridi, D., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.015 · Cited by 188
Systematic review of quality of life measures in patients with endometriosis
Bourdel, N., Chauvet, P., Billone, V., Douridas, G., Fauconnier, A., Gerbaud, L., & Canis, M. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0208464 · Cited by 171
Current and Emerging Therapeutics for the Management of Endometriosis
Ferrero, S., Barra, F., & Maggiore, U. L. R. (2018) · Drugs · doi:10.1007/s40265-018-0928-0 · Cited by 155
Metadata
- Authors
- Lee, D.-Y., Lee, J.-Y., Seo, J.-W., Yoon, B.-K., & Choi, D.
- Affiliations
- Samsung Medical Center (KR)
- Corresponding author
- Choi, DooSeok
- Venue
- Archives of Gynecology and Obstetrics
- Published
- 2016-08-22
- Volume
- 294
- Issue
- 6
- Pages
- 1257-1263
- ISSN
- 0003-9128 (ISSN-L)
- 0932-0067
- 1432-0711
- OpenAlex
- W2510120478
- Cited by
- 36
- References
- 29
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 8 · 2017: 5
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Gynecology and Obstetrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- endometriosis, GnRH agonist, add-back therapy, dienogest, laparoscopic surgery, estradiol, norethisterone acetate, quality of life, menopausal symptoms, bone mineral density, treatment tolerability
- MeSH terms
- Adult, Endometriosis, Estradiol, Female, Humans, Gonadotropin-Releasing Hormone, Nandrolone, Laparoscopy, Recurrence, Pelvic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gonadotropin-releasing hormone agonist with add–back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis. https://app.cochat.ai/papers/10.1007/s00404-016-4184-9
- The paper
- Lee, D.-Y., Lee, J.-Y., Seo, J.-W., Yoon, B.-K., & Choi, D. (2016). Gonadotropin-releasing hormone agonist with add–back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-016-4184-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.